Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug development.

Publication ,  Journal Article
Becker, RC
Published in: Journal of thrombosis and thrombolysis
April 2007

Duke Scholars

Published In

Journal of thrombosis and thrombolysis

DOI

EISSN

1573-742X

ISSN

0929-5305

Publication Date

April 2007

Volume

23

Issue

2

Start / End Page

159 / 161

Related Subject Headings

  • Stents
  • Stem Cells
  • Quinolines
  • Infusion Pumps, Implantable
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Fibrinolytic Agents
  • Endothelial Cells
  • Drug-Related Side Effects and Adverse Reactions
  • Drug Therapy
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Becker, R. C. (2007). Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug development. Journal of Thrombosis and Thrombolysis, 23(2), 159–161. https://doi.org/10.1007/s11239-006-0007-3
Becker, Richard C. “Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug development.Journal of Thrombosis and Thrombolysis 23, no. 2 (April 2007): 159–61. https://doi.org/10.1007/s11239-006-0007-3.
Becker, Richard C. “Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug development.Journal of Thrombosis and Thrombolysis, vol. 23, no. 2, Apr. 2007, pp. 159–61. Epmc, doi:10.1007/s11239-006-0007-3.
Journal cover image

Published In

Journal of thrombosis and thrombolysis

DOI

EISSN

1573-742X

ISSN

0929-5305

Publication Date

April 2007

Volume

23

Issue

2

Start / End Page

159 / 161

Related Subject Headings

  • Stents
  • Stem Cells
  • Quinolines
  • Infusion Pumps, Implantable
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Fibrinolytic Agents
  • Endothelial Cells
  • Drug-Related Side Effects and Adverse Reactions
  • Drug Therapy